首页> 美国卫生研究院文献>Applied and Environmental Microbiology >Production of Coenzyme A by a Mutant of Brevibacterium ammoniagenes Resistant to Oxypantetheine
【2h】

Production of Coenzyme A by a Mutant of Brevibacterium ammoniagenes Resistant to Oxypantetheine

机译:耐氧化泛素的产氨短杆菌突变体生产辅酶A

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

For improved production of coenzyme A (CoA), a mutant of Brevibacterium ammoniagenes IFO127071 resistant to oxypantetheine, the corresponding oxygen analog of pantetheine, was obtained. In the mutant, activity of pantothenate kinase (EC 2.7.1.33), the first-step enzyme for the biosynthesis of CoA from pantothenic acid, l-cysteine, and ATP, was about threefold higher than that in the parent strain. As the main regulation mechanism of CoA biosynthesis in this bacterium is negative feedback inhibition of pantothenate kinase by CoA, the mutant is very useful as a catalyst for practical production of CoA. When added to culture broth of the mutant, pantothenate, l-cysteine, and AMP gave 9.3 mg of CoA per ml. With pantetheine and AMP, 11.5 mg of CoA per ml accumulated. These values were about threefold higher than those with the parent strain, and more than 70% of the added AMP was converted to CoA.
机译:为了改善辅酶A(CoA)的产生,获得了氨丁酸短杆菌IFO127071的突变体,该突变体对泛素的相应氧类似物具有抗性。在该突变体中,泛酸激酶(EC 2.7.1.33)的活性是泛酸,L-半胱氨酸和ATP生物合成CoA的第一步酶,比亲本菌株高约三倍。由于该细菌中CoA生物合成的主要调控机制是CoA对泛酸激酶的负反馈抑制,因此该突变体非常有用,可作为实际生产CoA的催化剂。当添加到该突变体的培养液中时,泛酸,l-半胱氨酸和AMP产生9.3 mg CoA / ml。使用泛酸和AMP,每毫升累积了11.5 mg的CoA。这些值比亲本菌株高约三倍,并且超过70%的添加AMP被转化为CoA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号